You just read:

Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patients

News provided by

Intrinsic Therapeutics, Inc.

Apr 11, 2019, 05:00 ET